Growth Metrics

Inmune Bio (INMB) Leases (2019 - 2025)

Historic Leases for Inmune Bio (INMB) over the last 7 years, with Q3 2025 value amounting to $1.1 million.

  • Inmune Bio's Leases rose 21761.19% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year increase of 21761.19%. This contributed to the annual value of $307000.0 for FY2024, which is 2584.54% down from last year.
  • Inmune Bio's Leases amounted to $1.1 million in Q3 2025, which was up 21761.19% from $374000.0 recorded in Q2 2025.
  • Inmune Bio's Leases' 5-year high stood at $1.1 million during Q3 2025, with a 5-year trough of $128000.0 in Q3 2021.
  • In the last 5 years, Inmune Bio's Leases had a median value of $414000.0 in 2023 and averaged $443473.7.
  • Examining YoY changes over the last 5 years, Inmune Bio's Leases showed a top increase of 37445.26% in 2022 and a maximum decrease of 3016.53% in 2022.
  • Over the past 5 years, Inmune Bio's Leases (Quarter) stood at $726000.0 in 2021, then plummeted by 30.17% to $507000.0 in 2022, then dropped by 18.34% to $414000.0 in 2023, then fell by 25.85% to $307000.0 in 2024, then skyrocketed by 246.58% to $1.1 million in 2025.
  • Its Leases stands at $1.1 million for Q3 2025, versus $374000.0 for Q2 2025 and $278000.0 for Q1 2025.